Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-05 Sale | 2026-03-09 4:18 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 20,025 | $31.67 | $634,160 | 1,297,998 (Direct) | View |
| 2026-03-05 Sale | 2026-03-09 4:16 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, U.S. Commercial | 7,924 | $31.67 | $250,940 | 138,364 (Direct) | View |
| 2026-03-05 Sale | 2026-03-09 4:14 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 9,533 | $31.67 | $301,895 | 166,673 (Direct) | View |
| 2026-03-05 Sale | 2026-03-09 4:12 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard EVP, Europe Commercial | 17,295 | $31.67 | $547,705 | 137,642 (Direct) | View |
| 2026-03-05 Sale | 2026-03-09 4:10 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Jover Placid See "Remarks" | 14,150 | $31.67 | $448,108 | 49,227 (Direct) | View |
| 2026-03-05 Sale | 2026-03-09 4:09 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Savage Brian Interim Chief Legal Officer | 1,127 | $31.67 | $35,690 | 21,654 (Direct) | View |
| 2026-03-05 Sale | 2026-03-09 4:05 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shields Matthew EVP, Global Operations | 17,295 | $31.67 | $547,705 | 61,876 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:19 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 23,393 | $32.46 | $759,442 | 1,385,394 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:17 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard EVP, Europe Commercial | 91,345 | $32.66 | $2,983,517 | 160,102 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:09 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 11,277 | $32.46 | $366,102 | 194,736 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:05 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, U.S. Commercial | 9,098 | $32.46 | $295,362 | 166,576 (Direct) | View |
| 2026-03-04 Sale | 2026-03-06 4:03 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Savage Brian Interim Chief Legal Officer | 2,675 | $32.46 | $86,843 | 27,275 (Direct) | View |
| 2026-03-03 Sale | 2026-03-05 4:09 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard EVP, Europe Commercial | 128,985 | $32.36 | $4,173,942 | 185,380 (Direct) | View |
| 2026-03-03 Sale | 2026-03-05 4:06 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Savage Brian Interim Chief Legal Officer | 1,274 | $32.36 | $41,227 | 6,387 (Direct) | View |
| 2026-03-03 Sale | 2026-03-05 4:05 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 442,935 | $32.36 | $14,333,332 | 1,188,613 (Direct) | View |
| 2026-03-03 Sale | 2026-03-05 4:01 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 80,762 | $32.36 | $2,613,450 | 110,517 (Direct) | View |
| 2026-02-26 Sale | 2026-03-02 4:01 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 345,810 | $33.64 | $11,634,708 | 57,478 (Direct) | View |
| 2026-02-15 Sale | 2026-02-18 4:01 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 447,778 | $34.22 | $15,324,799 | 605,771 (Direct) | View |
| 2025-12-16 Sale | 2025-12-18 4:04 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 12,300 | $30.2 | $371,504 | 5,650 (Direct) | View |
| 2025-12-16 Sale | 2025-12-18 4:02 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director | 77,400 | $30.24 | $2,340,646 | 472,915 (Indirect Direct) | View |
| 2025-12-09 Sale | 2025-12-11 4:09 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 115,468 | $28.68 | $3,311,126 | 48,384 (Direct) | View |
| 2025-12-09 Sale | 2025-12-11 4:06 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 216,892 | $28.73 | $6,230,754 | 52,828 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-05 Exercise | 2026-03-09 4:23 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 15,723 | $0 | 334,212 (Direct) | View |
| 2026-03-05 Exercise | 2026-03-09 4:22 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 19,916 | $0 | 385,183 (Direct) | View |
| 2026-03-05 Exercise | 2026-03-09 4:19 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 3,537 | $0 | 41,308 (Direct) | View |
| 2026-03-05 Exercise | 2026-03-09 4:18 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 42,452 | $0 | 1,297,998 (Direct) | View |
| 2026-03-05 Exercise | 2026-03-09 4:16 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, U.S. Commercial | 17,819 | $0 | 138,364 (Direct) | View |
| 2026-03-05 Exercise | 2026-03-09 4:14 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 19,654 | $0 | 166,673 (Direct) | View |
| 2026-03-05 Exercise | 2026-03-09 4:12 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard EVP, Europe Commercial | 17,295 | $0 | 137,642 (Direct) | View |
| 2026-03-05 Exercise | 2026-03-09 4:10 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Jover Placid See "Remarks" | 14,150 | $0 | 49,227 (Direct) | View |
| 2026-03-05 Exercise | 2026-03-09 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Savage Brian Interim Chief Legal Officer | 3,580 | $0 | 21,654 (Direct) | View |
| 2026-03-05 Exercise | 2026-03-09 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shields Matthew EVP, Global Operations | 17,295 | $0 | 61,876 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 4:19 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 50,223 | $0 | 1,385,394 (Direct) | View |
| 2026-03-04 Option Award | 2026-03-06 4:19 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 136,736 | $0 | 1,385,394 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 4:17 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard EVP, Europe Commercial | 53,973 | $0 | 160,102 (Direct) | View |
| 2026-03-04 Option Award | 2026-03-06 4:17 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard EVP, Europe Commercial | 33,424 | $0 | 160,102 (Direct) | View |
| 2026-03-04 Option Award | 2026-03-06 4:16 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Jover Placid See "Remarks" | 37,982 | $0 | 37,982 (Direct) | View |
| 2026-03-04 Option Award | 2026-03-06 4:14 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shields Matthew EVP, Global Operations | 33,424 | $0 | 33,424 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 52,113 | $0 | 338,906 (Direct) | View |
| 2026-03-04 Option Award | 2026-03-06 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 30,385 | $0 | 338,906 (Direct) | View |
| 2026-03-04 Option Award | 2026-03-06 4:11 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Lippman Evan EVP, Business Development | 27,347 | $0 | 27,347 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 23,251 | $0 | 194,736 (Direct) | View |
| 2026-03-04 Option Award | 2026-03-06 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 50,643 | $0 | 194,736 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 4:08 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 56,763 | $0 | 405,197 (Direct) | View |
| 2026-03-04 Option Award | 2026-03-06 4:08 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 53,175 | $0 | 405,197 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, U.S. Commercial | 20,461 | $0 | 166,576 (Direct) | View |
| 2026-03-04 Option Award | 2026-03-06 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, U.S. Commercial | 50,643 | $0 | 166,576 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Savage Brian Interim Chief Legal Officer | 11,976 | $0 | 27,275 (Direct) | View |
| 2026-03-04 Option Award | 2026-03-06 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Savage Brian Interim Chief Legal Officer | 11,280 | $0 | 27,275 (Direct) | View |
| 2026-03-04 Exercise | 2026-03-06 4:01 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 16,329 | $0 | 49,738 (Direct) | View |
| 2026-03-04 Option Award | 2026-03-06 4:01 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 11,280 | $0 | 49,738 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 4:11 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 5,179 | $0 | 16,009 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard EVP, Europe Commercial | 203,728 | $0 | 185,380 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 4:08 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 166,378 | $0 | 244,107 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 4:06 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Savage Brian Interim Chief Legal Officer | 3,461 | $0 | 6,387 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 958,546 | $0 | 1,188,613 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 191,278 | $0 | 298,558 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 4:01 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 166,378 | $0 | 110,517 (Direct) | View |
Ownership | 2026-02-23 4:17 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Savage Brian Interim Chief Legal Officer | 0 | $0 | 69,692 (Direct) | View |
| 2026-02-15 Exercise | 2026-02-18 4:01 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 781,766 | $0 | 605,771 (Direct) | View |
| 2026-01-27 Option Award | 2026-01-29 4:07 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 141,478 | $0 | 141,478 (Direct) | View |
| 2026-01-27 Option Award | 2026-01-29 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 141,478 | $0 | 141,478 (Direct) | View |
| 2026-01-27 Option Award | 2026-01-29 4:04 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 141,478 | $0 | 141,478 (Direct) | View |
| 2026-01-27 Option Award | 2026-01-29 4:02 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 141,478 | $0 | 141,478 (Direct) | View |
| 2026-01-27 Option Award | 2026-01-29 4:01 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 1,511,425 | $0 | 1,511,425 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 4:09 pm | N/A 2028-02-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 115,468 | $0 | 48,384 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 15,011 | $16.99 | 48,384 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 4:09 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 100,457 | $18.61 | 48,384 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 4:06 pm | N/A 2028-02-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 118,724 | $0 | 52,828 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-11 4:06 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 118,724 | $18.61 | 52,828 (Direct) | View |